Hikma Slams Amarin In Vascepa Antitrust Suit For ‘Locking Up API Supply’

Fellow Icosapent ANDA Sponsor Dr Reddy’s Also Previously Filed Antitrust Suit

 
• By Dean Rudge

Amarin is facing up to another antitrust lawsuit over its alleged control of API supply for its Vascepa brand.

Antitrust law - Image
• Source: Shutterstock

More from Generics

More from Products